Conference Highlights
 |
The conference exceeded my expectations in terms of how
much I gained in knowledge and in the application of that knowledge in
my practice.
|
|
- Psychologist
|
|
|
|
|
|
Excellent presentations on executive functioning, RTI,
and current state of medication and ADHD
|
|
– Physician
|
|
Conference Highlights
 |
|
KEYNOTE SPEAKERS
Russell Barkley, Ph.D.
Dr. Barkley is the session presenter. He is a pre-eminent authority on
ADHD and author of the definitive text "ADHD: Handbook for Diagnosis and
Treatment". At the University of Massachusetts Medical School, Dr.
Barkley founded the ADHD Clinical Research Program, the first program of
its kind. Before joining Upstate Medical University's Department of
Psychiatry as Research Professor, he was Distinguished University
Professor of the Medical University of South Carolina in Charleston. Dr.
Barkley has written seven books, 54 chapters, 140 papers and is founding
editor of "The ADHD Report." Continuously funded by NIH since 1978,
Barkley has received 14 NIH grants totaling more than $7 million in
direct costs, many of which were competitively renewed.
The Role of Emotions and Emotional Control a keynote
address by Russell Barkley!
Thursday, November 11, 2010; 7:00 p.m. - 9:00 p.m.
Dr. Russell Barkley presents his latest conceptualization of ADHD,
particularly difficulties regulating emotions. In his keynote
address, The Role of Emotions and Emotional Control, Dr. Barkley
provides a thought-provoking discussion of how difficulties inhibiting
emotions interfere with everyday life. Barkley suggests that
“Children and adults with ADHD … are likely to appear to
others as less emotionally mature, more reactive with their feelings,
and more hot-headed, quick-tempered, and easily frustrated by
events” (www.russellbarkley.org). He will offer
strategies for managing these challenges.
Richard D. Lavoie, M.A., M.Ed.
Rick Lavoie served as an administrator of residential programs for
children with special needs for 30 years. He holds three degrees in
Special Education and holds two Honorary Doctorates in Education from
the University of Massachusetts (2003) and Mitchell College (CT –
2007). He has served as a visiting lecturer at numerous
universities including Syracuse, Harvard,, Manhattanville College,
University of Alabama, University of Melbourne and Georgetown. His
numerous national television appearances include The TODAY Show, CBS
Morning Show, Good Morning America, ABC Evening News, and Walt Disney
Presents.
Tales from the Road a keynote address by Rick Lavoie!
Friday, November 12, 2010; 8:30 a.m. - 10:00 a.m.
The Field of Learning Disabilities has undergone significant changes
over the past ten years. Trends, research and legislation have occurred
which impact upon the lives of children with Learning Disabilitiesand
those who teach and parent them. As a teacher, administrator, consultant
and national speaker, Rick has witnessed these developments from a
unique vantage point. By presenting anecdotes from his years as a
national speaker Rick will discuss the "state of the field" and its
impact upon some of the thousands of people that he has met during his
travels. This address, which served as the Opening Keynote for the 1996
International Learning Disabilities conference in Dallas, provides
valuable insights into the problems, challenges and issues in Special
Education today.
Sharon Weiss, M.Ed.
Sharon Weiss is a behavioral consultant in
private practice. Her areas of expertise include parent and staff
training in behavior management, specific skill training and crisis
intervention. She has worked as a teacher of special needs children,
program coordinator and supervisor of behavioral intervention programs
for behavior disordered children. Sharon is a highly sought after
speaker known for presenting practical, useful information in a humorous
way. She speaks nationally and internationally on topics such as
parenting and behavior management in both the home and educational
settings. She consults to private and public schools nationally, has
been on the faculty for courses for the American academy of pediatrics,
has taught college level courses on behavior and provides technical
assistance to area professionals. She has been featured on radio and
cable television programs, co-authored and is featured in a video, and
has co-authored two books.
What to do and Why? Strategies for Success a keynote
address by Sharon Weiss!
Saturday, November 13, 2010; 8:30 a.m. - 10:00 a.m.
What to Do and Why: Strategies for Success: Children and adolescents
with ADHD often present a greater behavioral challenge. Research
supports the benefits of both home and school- based interventions
leading to significant improvements in symptom management. With so much
information, it's hard to know where to start. This presentation is
designed to cut through some of the confusion, determine some basic
tools and approaches to behavior and provide specifics on how to apply
what you learn to your own life.
RESEARCH SYMPOSIA:
Research Symposium I: PRESIDENTAL MEDAL OF SCIENCE SYMPOSIUM
Friday, November 12, 2010; 10:30 a.m. -12:00 p.m.
During this panel discussion, each
of the experts will talk briefly about the top issues they consider
essential in providing evidence-based treatments for ADHD – what
works, what doesn’t, and what to do when a treatment does not seem
to be as effective as it should. A Q & A segment will follow the
presentations.
Joanna S. Fowler, Ph.D.; PET Imaging in Adults with
ADHD
 Fowler received her Ph.D. in chemistry from the
University of Colorado and did her postdoctoral work at the University
of East Anglia in England and at Brookhaven. She is also an Adjunct
Professor in the Chemistry and Biomedical Engineering departments at
Stony Brook University. In 1976, Fowler's research has led to
fundamental new knowledge, important scientific tools and broad impact
in the application of nuclear medicine to diagnostics and health. She
has worked for much of her career developing radiotracers for brain
imaging to understand the mechanisms underlying drug addiction. Most
recently, she has been engaged in developing methods to understand the
relationship between genes, brain chemistry and behavior. Fowler played
a central role in the development of a fluorine-18-labeled glucose
molecule (FDG) enabling human brain glucose metabolism to be measured
noninvasively. This positron-emitting molecule, together with positron
emission tomography (PET) imaging, has become a mainstay for
brain-imaging studies in schizophrenia, aging and cancer. Fowler's
interest in monoamine oxidase (MAO), one of the two major enzymes
involved in neurotransmitter regulation in the brain and peripheral
organs, led her to develop the first radiotracers for imaging MAO in the
human brain and in peripheral organs like the lungs and kidneys. This
led to the discovery that smokers have reduced brain and lung MAO and to
many studies relating reduced MAO to some of the behavioral and
epidemiological features of smoking.
Michael I. Posner, Ph.D.; Attention Networks and Training of
Children with ADHD
 Michael Posner is currently
Professor Emeritus at the University of Oregon and Adjunct Prof. of
Psychology in Psychiatry at the Weill Medical College of Cornell, where
he served as founding director of the Sackler Institute. Posner
developed with Marcus Raichle studies of imaging the human brain during
cognitive tasks He has also worked on the anatomy, circuitry,
development and genetics of three attentional networks underlying
maintaining alertness, orienting to sensory events and voluntary control
of thoughts and ideas. His methods for measuring these networks have
been applied to a wide range of neurological, psychiatric and
developmental disorders and to normal development and school
performance. His current research involves a longitudinal study of
children prior to school designed to understand the interaction of
specific experience and genes in shaping attention and self regulation.
His work has been recognized by election to the National Academy of
Sciences and the American Academy of Arts and Sciences, by 7 honorary
degrees and by the Distinguished Science Award of the American
Psychological Association, the Karl Lashley Award by the American
Philosophical Society and the Dogan award from the International Union
of Psychology and the National Medal of Science USA.
James Swanson, Ph.D. (Facilitator)
 Dr. Swanson is a developmental psychologist who
specializes in research and the treatment of children with ADHD. His
initial work at the University of California, Irvine focused on
school-based interventions for children with ADHD, establishing a public
school on the UCI campus where clinical and educational interventions
were combined. Starting in 1990, the focus of Dr. Swanson’s
research expanded to address etiology of ADHD. Dr. Swanson developed a
laboratory school paradigm that has become a standard method for
evaluating the efficacy of psychoactive medications for the treatment of
children with ADHD. Dr. Swanson received his Ph.D. in psychology from
the Ohio State University in 1970.
Research Symposium II: PRESCRIPTIONS
FOR STIMULANTS IN THE USA FROM 2000-2009
Saturday, November 13, 2010;10:30 a.m. - 12:00 p.m.
Presidential Medal os Science
Symposium: Dr. Michael Psner and Joanna Fowler are in an elite group of
10 scientists who were awarded this honor by President Barack Obama in
2009. This is the nation's highest award for lifetime science
achievement. CHADD is fortunate to have these esteemed senior scientists
discuss innovative neuroscience research.
1. PET Imaging in Adults with ADHD with Joanna Fowler, Ph.D.: Dr.
Fowler’s pioneering work in chemistry informed the development of
PET imaging techniques. She applied PET imaging to investigate changes
in brain circuitry exploring the therapeutic and additive properties of
drugs.
2. Attention Networks and Training of Children with ADHD with Michael
Posner, Ph.D.: Dr. Posner significantly advanced our understanding of
the neural mechanisms and structures underlying attention and memory
networks. Using PET technology, Dr. Posner studied brain activation
patterns during simple and complex cognitive tasks.
James Swanson, Ph.D.; Prescriptions for Stimulants in the USA from
2000 to 2009
Dr. Swanson is a developmental psychologist who
specializes in research and the treatment of children with ADHD. His
initial work at
the University of California, Irvine focused on school-based
interventions for children with ADHD, establishing a public school on
the UCI campus where clinical and educational interventions were
combined. Starting in 1990, the focus of Dr. Swanson’s research
expanded to address etiology of ADHD. Dr. Swanson developed a laboratory
school paradigm that has become a standard method for evaluating the
efficacy of psychoactive medications for the treatment of children with
ADHD. Dr. Swanson received his Ph.D. in psychology from the Ohio State
University in 1970.
Susanna Visser, M.S.; Prevalence and Prescription Rates
in ADHD
 Susanna Visser came to CDC in 2001 and is the lead
Epidemiologist for the Child Development Studies team at the Centers for
Disease Control and Prevention (CDC). She serves as the committee
epidemiologist for the American Academy of Pediatrics ADHD diagnostic
and treatment guidelines committee and has participated in technical
expert panels for national surveys directed by the Maternal Child Health
Bureau. Ms. Visser's expertise includes the analysis of longitudinal and
population-based survey data as well as the epidemiologic study of
neurobehavioral and mental health conditions. Lead author
publications include research related to generating population-based
estimates of ADHD, rates of medication treatment among youth with ADHD,
and factors associated with ADHD medication treatment. Ms. Visser
currently directs federal research contracts investigating developmental
outcomes of youth with physical and social health risk factors.
THROUGH THE LOOKING GLASS: GAZE INTO THE FUTURE OF DSM-5
Thursday, November 11, 2010; 1:30 p.m. - 4:30 p.m.
CHADD has scheduled an opportunity for attendees to learn about the
latest proposed guidelines for the assessment and treatment of ADHD. The
DSM-5 Panel Explores Future Diagnosis and Treatment Guides for ADHD in
children and adults featuring Drs. Abramowitz, Barkley, Goldstein, Nigg,
and Swanson who explore the strengths and shortcomings of the proposed
changes in the diagnostic criteria for ADHD. Presenters provide their
arguments within a research context and explore how these changes will
affect clinical practices.
Ann Abramowitz, Ph.D.
 Dr. Abramowitz is the session chair. Dr.
Abramowitz is a clinical psychologist and full-time faculty member at
Emory University. She is the Coordinator of Assessment Training in the
Clinical Psychology doctoral program, and teaches and supervises
psychological assessment, child and family therapy, and school-based
interventions. She is the Chair of CHADD's national Professional
Advisory Board, and consults on ADHD to the Centers for Disease Control
and Prevention. She was a co-investigator on the National Institute of
Mental Health's Multimodal Treatment Study of Children with Attention
Deficit Hyperactivity Disorder (MTA). Prior to her current career, she
was a special education teacher and the special education coordinator
for a school district.
Russell Barkley, Ph.D.
Dr. Barkley is the session
discussant. He is a pre-eminent authority on ADHD and author of the
definitive text "ADHD: Handbook for Diagnosis and Treatment". At the
University of Massachusetts Medical School, Dr. Barkley founded the ADHD
Clinical Research Program, the first program of its kind. Before joining
Upstate Medical University's Department of Psychiatry as Research
Professor, he was Distinguished University Professor of the Medical
University of South Carolina in Charleston. Dr. Barkley has written
seven books, 54 chapters, 140 papers and is founding editor of "The ADHD
Report." Continuously funded by NIH since 1978, Barkley has received 14
NIH grants totaling more than $7 million in direct costs, many of which
were competitively renewed.
Sam Goldstein, Ph.D.
 Dr. Sam Goldstein is an Assistant Clinical
Professor at the University of Utah School of Medicine. He has been in
practice as a clinical neuropsychologist for twenty-six years. He is the
current Editor of the Journal of Attention Disorders and sits on six
editorial boards for scientific journals. He is the author, co-author
and editor of twenty-two scientific and trade texts, including a number
of major textbooks in ADHD. Dr. Goldstein is author of two dozen book
chapters and nearly two dozen peer reviewed scientific research studies
as well as hundreds of lay articles. He has lectured nationally and
internationally with approximately thirty presentations per year over
the past twenty years.
Joel Nigg, Ph.D.
 Dr. Nigg obtained his A.B at Harvard and his
Ph.D. at University of California-Berkeley. He is currently the director
of the Psychology Division and Professor of Psychiatry and Behavioral
Neuroscience at Oregon Health and Science University. He has published
over 100 scientific papers on ADHD, personality, temperament, and
developmental psychopathology. He is the author of What Causes ADHD
(Guilford Press, 2006), a book that provides a scholarly review of
causes and mechanisms in ADHD. His scientific investigations have been
funded by the National Institute of Mental health continuously for over
a decade. He is on the editorial boards of several major scientific
journals, is a highly cited scientist, and a licensed clinician who has
worked with families struggling with ADHD.
James Swanson, Ph.D.
Dr. Swanson is a developmental psychologist who
specializes in research and the treatment of children with ADHD. His
initial work at the University of California, Irvine focused on
school-based interventions for children with ADHD, establishing a public
school on the UCI campus where clinical and educational interventions
were combined. Starting in 1990, the focus of Dr. Swanson’s
research expanded to address etiology of ADHD. Dr. Swanson developed a
laboratory school paradigm that has become a standard method for
evaluating the efficacy of psychoactive medications for the treatment of
children with ADHD. Dr. Swanson received his Ph.D. in psychology from
the Ohio State University in 1970.
ADHD AND ITS LINK TO LAW ENFORCEMENT
Thursday, November 11, 2010; 1:30 p.m. - 4:30 p.m.
Save
the Date!
This session will address what ADHD is, its implications for law
enforcement and the criminal justice system, and what can be done to
improve interventions and outcomes. Suggestions will be provided on how
to manage a young person with ADHD in custody and how to engage local
CHADD chapters in partnership work. Speakers will 1. Review ADHD and its
links to criminal behavior, in the context of social determinants of
health behavior; 2. Demonstrate how the disorder affects the individual
and the operations of police and juvenile justice agencies; and 3.
Provide examples of more appropriate early interventions to improve
legal outcomes of youths with ADHD.
Phillip Anderton, Ph.D.
Phil Anderton served as a police
officer in excess of 27 years and has commenced a new career as a
management consultant. His interest in AD/HD was born out of his
responsibilities in Lancashire (UK) for youth crime and mental health
issues. Working with a colleague Steve Brown, on an premise that
prevention concepts had a long way to go before they became totally
effective, he began researching mental health disorders and in
particular AD/HD. He now works alongside ADDISS as their criminal
justice advisor and delivers presentations across Europe and has spoken
at the last two CHADD conferences. He is the author of a book on the
subject of ADHD and crime that is focused on professionals that work
with young people who have the disorder.
Steven Brown, Sgt.
Steve Brown has been a police officer
for 20 years and a sergeant for the last 10 of these. He has been in the
field of community safety for 4 years. He has concentrated on youth
issues and developed youth intervention schemes to prevent offending. He
became aware of AD/HD through a presentation given by a local support
group and has for the last 4 years been working to develop a criminal
justice based program to reduce offending by young people with AD/HD.
Together with Phillip Anderton, he presented at a previous CHADD
conference and since then they developed their work to become based
around schools and also looked at the links of AD/HD to substance
misuse. He has also presented his work at various national conferences
helping other Police services develop their own programs in this
field.
HOPE, HUMOR AND HONORS
Friday, November 12, 2010; 7:00 p.m. - 9:15 p.m.
Join us for an evening of food, education and entertainment as we
recognize individuals who have made outstanding contributions to improve
the lives of people with ADHD ($25). Master of Ceremonies: Kevin
Roberts, M.A.
• Matt Morgan, TNA Wrestling
television star, shares his story how he struggled with ADD was a child
and how through the help of his family and teachers he became the
success that he is today in the wrestling ring, television and in life
today.
• Learn and receive continuing education credits with Sam
Goldstein, Ph.D., who will present, A Good Day is When Bad Things
Don’t Happen – Revisited.
Matt Morgan
 Morgan was first introduced to the World Wrestling Federation
when he entered as part of its Tough Enough II program but left the show
early due to an injury. In April 2002, Morgan signed a developmental
deal with World Wrestling Entertainment (WWE), and was assigned to Ohio
Valley Wrestling (OVW). He made is OVW debut on October 2, 2002 at the
OVW TV Tapings as “The Blueprint” Matt Morgan teaming with
Mark Jindrak, defeating Bane and Lance Cade. He wrestled there
sporadically (usually winnning handicap matches) until October 2003 when
he was called up to the SmackDown brand.
Morgan announced on an episode of TNA Impact! During the TNA Webography
segment where TNA Superstars give an insight into their life that he has
been married to his college sweetheart, a Hawaiian/Filipino woman named
Larissa Vasper from Hawaii for five years. During the Webography, he
also announced that when he was five, he was diagnosed with
Attention-Deficit Hyperactivity Disorder (ADHD). This is when he started
to get involved with CHADD, Children and Adults with Attention Deficit
Hyperactivity Disorder.
Sam Goldstein, Ph.D.
Dr. Sam Goldstein is an Assistant
Clinical Professor at the University of Utah School of Medicine. He has
been in practice as a clinical neuropsychologist for twenty-six years.
He is the current Editor of the Journal of Attention Disorders and sits
on six editorial boards for scientific journals. He is the author,
co-author and editor of twenty-two scientific and trade texts, including
a number of major textbooks in ADHD. Dr. Goldstein is author of two
dozen book chapters and nearly two dozen peer reviewed scientific
research studies as well as hundreds of lay articles. He has lectured
nationally and internationally with approximately thirty presentations
per year over the past twenty years.
|
